Cancer statistics, 2016

By R. Siegel, K. Miller, A. Jemal. Ca, 2016

14,496 citations recorded by the source corpus.

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009‐2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth‐19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2016;7–30. © 2015 American Cancer Society.

Subfields: Economics and Econometrics, Oncology

View Paper: https://www.semanticscholar.org/paper/02e70a69005abf21219271f460161ea4d1650dd9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

  1. R. Siegel
  2. A. Jemal
  3. B. Han
  4. J. Chao
  5. Honghong Yao
  6. Gustavo Carneiro
  7. Ian David Reid
  8. Michael W. Kattan

In Oncology

  1. R. Siegel
  2. A. Jemal
  3. Noel C. F. Codella
  4. Allan Halpern
  5. P. Heng
  6. Hao Chen
  7. Elizabeth E. Ward
  8. Brian Helba

Citations in the corpus